We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
NO CONSENSUS ON ELLA.
- Authors
Brehany, John F.
- Abstract
When the FDA labeled ulipristal acetate (UPA; Ella is the product sold in the United States by HRA Pharma) an "emergency contraceptive," Catholic and pro-life leaders criticized the decision, identified Ella as an abortifacient, and agreed it should not be used by Catholic institutions and providers.1 Ron Hamel, senior ethicist for the Catholic Health Association, shared this conclusion.2 In 2014, however, Hamel ended a review article by stating, "If, however, the consensus is correct, then there would seem to be sufficient moral certitude at this time to make use of UPA in Catholic hospitals." 3 Below I question whether a relevant consensus exists and argue that the scientific evidence militates against, rather than in favor of, use of UPA/Ella by Catholic providers.
- Subjects
ACETATE derivatives; HRA Pharma SA; HUMAN ecology; SOCIAL ecology; BIOLOGY; UNITED States. Food &; Drug Administration
- Publication
Ethics & Medics, 2016, Vol 41, Issue 2, p2
- ISSN
1071-3778
- Publication type
Article
- DOI
10.5840/em20164123